ALK(SZ:002940) Xin Lang Cai Jing·2025-11-12 03:29Group 1 - The core point of the news is that Anglikang's stock price increased by 5.09%, reaching 44.81 CNY per share, with a trading volume of 1.039 billion CNY and a turnover rate of 12.94%, resulting in a total market capitalization of 9.039 billion CNY [1] - Anglikang Pharmaceutical Co., Ltd. is located in Shengzhou, Zhejiang Province, and was established on December 30, 2001. The company was listed on October 23, 2018, and its main business involves the research, production, and sales of chemical raw materials and formulations [1] - The revenue composition of Anglikang's main business includes formulations at 43.46%, raw materials at 39.82%, specialty intermediates at 12.44%, other products at 3.72%, and pharmaceutical excipients at 0.56% [1] Group 2 - From the perspective of major fund holdings, one fund under Tongtai Fund has a significant position in Anglikang. The Tongtai Health Theme Mixed A Fund (011002) held 66,200 shares in the third quarter, accounting for 4.99% of the fund's net value, making it the sixth-largest holding [2] - The Tongtai Health Theme Mixed A Fund (011002) was established on April 8, 2021, with a latest scale of 13.7512 million CNY. Year-to-date, it has achieved a return of 21.89%, ranking 4112 out of 8147 in its category; over the past year, it has returned 9.34%, ranking 5366 out of 8056; since inception, it has incurred a loss of 49.99% [2] Group 3 - The fund managers of Tongtai Health Theme Mixed A Fund (011002) are Ma Yi and Mai Jianpei. As of the report, Ma Yi has a cumulative tenure of 11 years and 241 days, with a total fund asset size of 2.718 billion CNY, achieving a best fund return of 45.64% and a worst return of -0.63% during his tenure [3] - Mai Jianpei has a cumulative tenure of 185 days, with a total fund asset size of 231 million CNY, achieving a best fund return of 21.48% and a worst return of -1.56% during his tenure [3]